Metastasis to the Sellar/Suprasellar Region in a Patient with Endometrial Carcinoma Detected by 18F-FDG PET/CT

Barbara Salvatore, Domenico D'Amico, Rosa Fonti

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Metastases to pituitary gland, suprasellar region or skull base from endometrial carcinoma are an extremely rare occurrence. We report the case of a 77-year-old woman with metastasis to the sellar/suprasellar region from endometrial carcinoma revealed by 18F-FDG PET/CT and confirmed by subsequent CT and MRI of the brain. This case highlights the usefulness of a whole-body imaging methodology such as 18F-FDG PET/CT in the detection of distant and/or atypical sites of metastasis therefore being of help in guiding towards the correct diagnosis.

Original languageEnglish
Pages (from-to)363-364
Number of pages2
JournalClinical Nuclear Medicine
Volume43
Issue number5
DOIs
Publication statusPublished - May 1 2018

Fingerprint

Fluorodeoxyglucose F18
Endometrial Neoplasms
Neoplasm Metastasis
Whole Body Imaging
Skull Base
Pituitary Gland
Brain

Keywords

  • F-FDG PET/CT
  • endometrial carcinoma
  • sellar region

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Metastasis to the Sellar/Suprasellar Region in a Patient with Endometrial Carcinoma Detected by 18F-FDG PET/CT. / Salvatore, Barbara; D'Amico, Domenico; Fonti, Rosa.

In: Clinical Nuclear Medicine, Vol. 43, No. 5, 01.05.2018, p. 363-364.

Research output: Contribution to journalArticle

@article{9a3ca14423dc41b9bb89043e55564d6e,
title = "Metastasis to the Sellar/Suprasellar Region in a Patient with Endometrial Carcinoma Detected by 18F-FDG PET/CT",
abstract = "Metastases to pituitary gland, suprasellar region or skull base from endometrial carcinoma are an extremely rare occurrence. We report the case of a 77-year-old woman with metastasis to the sellar/suprasellar region from endometrial carcinoma revealed by 18F-FDG PET/CT and confirmed by subsequent CT and MRI of the brain. This case highlights the usefulness of a whole-body imaging methodology such as 18F-FDG PET/CT in the detection of distant and/or atypical sites of metastasis therefore being of help in guiding towards the correct diagnosis.",
keywords = "F-FDG PET/CT, endometrial carcinoma, sellar region",
author = "Barbara Salvatore and Domenico D'Amico and Rosa Fonti",
year = "2018",
month = "5",
day = "1",
doi = "10.1097/RLU.0000000000002037",
language = "English",
volume = "43",
pages = "363--364",
journal = "Clinical Nuclear Medicine",
issn = "0363-9762",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Metastasis to the Sellar/Suprasellar Region in a Patient with Endometrial Carcinoma Detected by 18F-FDG PET/CT

AU - Salvatore, Barbara

AU - D'Amico, Domenico

AU - Fonti, Rosa

PY - 2018/5/1

Y1 - 2018/5/1

N2 - Metastases to pituitary gland, suprasellar region or skull base from endometrial carcinoma are an extremely rare occurrence. We report the case of a 77-year-old woman with metastasis to the sellar/suprasellar region from endometrial carcinoma revealed by 18F-FDG PET/CT and confirmed by subsequent CT and MRI of the brain. This case highlights the usefulness of a whole-body imaging methodology such as 18F-FDG PET/CT in the detection of distant and/or atypical sites of metastasis therefore being of help in guiding towards the correct diagnosis.

AB - Metastases to pituitary gland, suprasellar region or skull base from endometrial carcinoma are an extremely rare occurrence. We report the case of a 77-year-old woman with metastasis to the sellar/suprasellar region from endometrial carcinoma revealed by 18F-FDG PET/CT and confirmed by subsequent CT and MRI of the brain. This case highlights the usefulness of a whole-body imaging methodology such as 18F-FDG PET/CT in the detection of distant and/or atypical sites of metastasis therefore being of help in guiding towards the correct diagnosis.

KW - F-FDG PET/CT

KW - endometrial carcinoma

KW - sellar region

UR - http://www.scopus.com/inward/record.url?scp=85045657074&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045657074&partnerID=8YFLogxK

U2 - 10.1097/RLU.0000000000002037

DO - 10.1097/RLU.0000000000002037

M3 - Article

C2 - 29485436

AN - SCOPUS:85045657074

VL - 43

SP - 363

EP - 364

JO - Clinical Nuclear Medicine

JF - Clinical Nuclear Medicine

SN - 0363-9762

IS - 5

ER -